Osteoporosis Disease Management Demonstration Project (0000-037)

Not Applicable

Completed

• Conditions: Osteoporosis

• Registration Number: NCT00139425
• Lead Sponsor: Merck Sharp & Dohme LLC

Brief Summary

The purpose of this study is to assess the impact of disease management interventions on bone mineral density (BMD) screening rates and osteoporosis treatment rates in women age 65 years or older.

Detailed Description

Not available

Study Timeline

• Study Start: 2003-05
• Primary Completion: 2004-12
• Study Completion: 2004-12
• Study First Submitted: 2005-08-29
• Study First Submitted QC: 2005-08-30
• Study First Posted: 2005-08-31
• Status Verified: 2016-04
• Last Update Submitted: 2016-04-21
• Last Update Posted: 2016-04-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 10000

Inclusion Criteria

• Members of the Henry Ford Health System

Exclusion Criteria

• Individuals who are not members of the Henry Ford Health System

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Bone mineral density (BMD) testing rates

Secondary Outcome Measures

Name	Time	Method
Osteoporosis medication treatment rates